|
Corrona Atopic Dermatitis Registry:
A Study of Post Approval Drug Safety and Effectiveness
|
|
21-074-2
|
|
Corrona Atopic Dermatitis Registry:
A Study of Post Approval Drug Safety and Effectiveness
|
|
Dr. Jun Lu
|
|
The objective of the Corrona Atopic Dermatitis (AD) Registry is to create a national cohort of patients with atopic dermatitis. Data collected will be used to extensively evaluate the effectiveness and safety of medications used to treat atopic dermatitis. This will be done through the standardized collection of patient-reported outcomes (PRO) and clinician-reported outcomes (ClinRO), and the prevalence and incidence of comorbidities and adverse events, medication utilization patterns, and patient productivity measures.Personal information is also collected from each consenting registry patient allowing for linkages to other public or private clinical and administrative databases, as well as to databases maintained by organizations focused on the care and treatment of atopic dermatitis for the purposes of clinical, market, or outcomes research. This provides an opportunity to evaluate other aspects of the disease and its treatment including but not limited to clinical and drug cost-effectiveness, healthcare resource utilization, and patient adherence.
|
Skin
|
|
|
Check with study contact
|
|
Margaret Toro. Telephone (860) 679-8175. Email: mtoro@uchc.edu or Ektor Rafti. Telephone: 860-679-3475 Email: ERafti@uchc.edu
|
|
Enrolling/recruiting. For current recruitment status, please check with study contact.
|
|
|